Aspen Pharmacare Gross Profit 2017-2023 | APNHY
Aspen Pharmacare annual/quarterly gross profit history and growth rate from 2017 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Aspen Pharmacare gross profit for the quarter ending June 30, 2023 was $M, a NAN% increase year-over-year.
- Aspen Pharmacare gross profit for the twelve months ending June 30, 2023 was $0M, a NAN% increase year-over-year.
- Aspen Pharmacare annual gross profit for 2023 was $1.068B, a 11.35% decline from 2022.
- Aspen Pharmacare annual gross profit for 2022 was $1.205B, a 3.85% increase from 2021.
- Aspen Pharmacare annual gross profit for 2021 was $1.16B, a 6.84% decline from 2020.
Aspen Pharmacare Annual Gross Profit
(Millions of US $) |
| 2023 |
$1,068 |
| 2022 |
$1,205 |
| 2021 |
$1,160 |
| 2020 |
$1,245 |
| 2019 |
$1,389 |
| 2018 |
$1,687 |
| 2017 |
$1,463 |
| 2016 |
$1,242 |
| 2015 |
$ |
Aspen Pharmacare Quarterly Gross Profit
(Millions of US $) |
| 2023-06-30 |
|
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2020-06-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2016-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.038B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
